Close

Amgen's (AMGN) Trebananib ESMO Safety Data 'Good' - Leerink Swann

October 2, 2013 10:27 AM EDT Send to a Friend
Leerink Swann today maintained a Market Perform rating on Amgen (NASDAQ: AMGN) with a price target of $128.00. Analyst Howard ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login